Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Wessel

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Memory (Hove, England)|February 1, 2024
The effects of eye movements on the content and characteristics of unpleasant autobiographical memories: an extended replication studyH I Meckling, M H Nauta, W J P J van Hout, et al.
FEBS Letters|October 18, 2000
N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistanceL H Jensen, I Wessel, M Møller, et al.
Cancer Research|October 23, 1997
Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localizationI Wessel, P B Jensen, J Falck, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 26, 1999
Self-mutilating behaviour of psychiatric inpatientsH L Nijman, M Dautzenberg, H L Merckelbach, et al.
Cancer Research|July 23, 1999
Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoformI Wessel, L H Jensen, P B Jensen, et al.
Anti-Cancer Drug Design|October 12, 2002
Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell linesL Rothenborg-Jensen, H F Hansen, I Wessel, et al.
Cancer Research|April 16, 1998
Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazinesM Sehested, I Wessel, L H Jensen, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|March 23, 2011
Posttraumatic stress disorder following preeclampsia and PPROM: a prospective study with 15 months follow-upC A I Stramrood, I Wessel, B Doornbos, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 13, 2019
PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinomaA Nøhr, S B Gram, B Charabi, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Memory (Hove, England)|February 1, 2024
The effects of eye movements on the content and characteristics of unpleasant autobiographical memories: an extended replication studyH I Meckling, M H Nauta, W J P J van Hout, et al.
FEBS Letters|October 18, 2000
N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistanceL H Jensen, I Wessel, M Møller, et al.
Cancer Research|October 23, 1997
Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localizationI Wessel, P B Jensen, J Falck, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 26, 1999
Self-mutilating behaviour of psychiatric inpatientsH L Nijman, M Dautzenberg, H L Merckelbach, et al.
Cancer Research|July 23, 1999
Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoformI Wessel, L H Jensen, P B Jensen, et al.
Anti-Cancer Drug Design|October 12, 2002
Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell linesL Rothenborg-Jensen, H F Hansen, I Wessel, et al.
Cancer Research|April 16, 1998
Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazinesM Sehested, I Wessel, L H Jensen, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|March 23, 2011
Posttraumatic stress disorder following preeclampsia and PPROM: a prospective study with 15 months follow-upC A I Stramrood, I Wessel, B Doornbos, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 13, 2019
PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinomaA Nøhr, S B Gram, B Charabi, et al.
Pageof 3